REPL -
Replimune Group, Inc.
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 4.4 0.2 (4.55%) |
--- |
--- |
0.0 (0.0%) |
0.0 (0.0%) |
0.38 (8.72%) |
-0.05 (-1.08%) |
-0.05 (-1.08%) |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Earnings & Ratios
- Basic EPS:
- -0.95
- Diluted EPS:
- -0.95
- Basic P/E:
- -4.8421
- Diluted P/E:
- -4.8421
- RSI(14) 1m:
- 0.0
- VWAP:
- 4.6
- RVol:
- 0.6912
Events
| Period |
Kind |
Movement |
Occurred At |
| 1m |
Price increase 1m |
4.63 +0.06 (+1.34%) |
Oct 15 16:29 |
| 1m |
Price increase 1m |
4.74 +0.08 (+1.61%) |
Oct 15 15:59 |
Related News
REPL FINAL DEADLINE ALERT: Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman
Sep 21, 2025 15:20
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
Sep 21, 2025 11:40
REPL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL
Sep 21, 2025 10:09
מחר המועד האחרון לתביעה נגד REPL: רוזן, יועץ למשקיעים מיומן, מעודד את משקיעי Replimune Group, Inc. שצברו הפסדים של יותר מ- 100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך שהוגשה ראשונה על ידי המשרד – REPL
Sep 21, 2025 10:09
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd
Sep 17, 2025 22:00
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Sep 17, 2025 16:00
Replimune Group, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 22, 2025 Deadline to file Lead Plaintiff Motion.
Sep 16, 2025 20:53
REPL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm – REPL
Sep 16, 2025 01:24
Contact The Gross Law Firm by September 22, 2025 Deadline to Join Class Action Against Replimune Group, Inc. (REPL)
Sep 15, 2025 19:58
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (NASDAQ: REPL)
Sep 15, 2025 11:00